JP Morgan Chase’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
276,412
+244,655
+770% +$1.57M ﹤0.01% 4186
2025
Q4
$179K Sell
31,757
-3,946
-11% -$21.4K ﹤0.01% 5596
2025
Q3
$220K Buy
35,703
+1,324
+4% +$7.74K ﹤0.01% 5463
2025
Q2
$167K Buy
34,379
+18,094
+111% +$64K ﹤0.01% 5331
2025
Q1
$60.3K Sell
16,285
-939,647
-98% -$4.02M ﹤0.01% 5801
2024
Q4
$3.82M Buy
955,932
+945,863
+9,394% +$5.19M ﹤0.01% 3604
2024
Q3
$70.2K Buy
10,069
+447
+5% +$3.63K ﹤0.01% 5858
2024
Q2
$54.6K Sell
9,622
-60,655
-86% -$543K ﹤0.01% 5819
2024
Q1
$936K Buy
70,277
+70,144
+52,740% +$656K ﹤0.01% 4394
2023
Q4
$817 Hold
133
﹤0.01% 6862
2023
Q3
$335 Hold
133
﹤0.01% 6777
2023
Q2
$697 Hold
133
﹤0.01% 6507
2023
Q1
$1K Hold
133
﹤0.01% 6548
2022
Q4
$1K Sell
133
-294
-69% -$1.93K ﹤0.01% 6439
2022
Q3
$3K Buy
427
+109
+34% +$1.1K ﹤0.01% 6195
2022
Q2
$3K Sell
318
-2,417
-88% -$25.1K ﹤0.01% 6248
2022
Q1
$50K Sell
2,735
-2,435
-47% -$43K ﹤0.01% 5799
2021
Q4
$136K Buy
5,170
+3,641
+238% +$111K ﹤0.01% 5548
2021
Q3
$55K Hold
1,529
﹤0.01% 5812
2021
Q2
$84K Sell
1,529
-5,142
-77% -$340K ﹤0.01% 5600
2021
Q1
$553K Sell
6,671
-4,106
-38% -$454K ﹤0.01% 4617
2020
Q4
$1.22M Buy
10,777
+3,464
+47% +$219K ﹤0.01% 3824
2020
Q3
$225K Sell
7,313
-5,269
-42% -$202K ﹤0.01% 4309
2020
Q2
$553K Sell
12,582
-5,438
-30% -$226K ﹤0.01% 3814
2020
Q1
$646K Buy
18,020
+10,845
+151% +$537K ﹤0.01% 3690
2019
Q4
$479K Sell
7,175
-633
-8% -$69.9K ﹤0.01% 4262
2019
Q3
$1.21M Buy
7,808
+436
+6% +$49.3K ﹤0.01% 3722
2019
Q2
$559K Sell
7,372
-495
-6% -$54K ﹤0.01% 4191
2019
Q1
$1.08M Sell
7,867
-109,958
-93% -$27.5M ﹤0.01% 3756
2018
Q4
$47.4M Sell
117,825
-86,113
-42% -$40.5M 0.01% 922
2018
Q3
$144M Sell
203,938
-9,149
-4% -$5.75M 0.03% 557
2018
Q2
$114M Sell
213,087
-9,687
-4% -$2.98M 0.02% 606
2018
Q1
$25.1M Buy
+222,774
New +$75.2M 0.01% 1358

Other funds holding SLDB